MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database. (Q30380647)

21 June 2017

MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database. (English)

1 reference

21 June 2017

0 references

1 reference

Michele Pellegrini

1

0 references

author name string

Uwe Nicolay

2

1 reference

21 June 2017

Kelly Lindert

3

1 reference

21 June 2017

Nicola Groth

4

1 reference

21 June 2017

Giovanni Della Cioppa

5

1 reference

21 June 2017

language of work or name

English

0 references

publication date

12 September 2009

1 reference

21 June 2017

1 reference

21 June 2017

27

1 reference

21 June 2017

6959-6965

1 reference

21 June 2017

49

1 reference

Antibody response to influenza vaccination in the elderly: a quantitative review

21 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.101

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.101

The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.101

Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.101

Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.101

Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.101

Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.101

Comparison of three different influenza vaccines in institutionalised elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.101

Response to influenza vaccine in people with non-protective HI antibody titers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.101

A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.101

Response of influenza vaccines against heterovariant influenza virus strains in adults with chronic diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.101

Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.101

Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: the importance of cross-protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.101

Vaccination and autoimmune disease: what is the evidence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.101

Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.101

Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.101

Development of an adjuvant to enhance the immune response to influenza vaccine in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.101

Decline in influenza-associated mortality among Dutch elderly following the introduction of a nationwide vaccination program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.101

Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.101

10.1016/J.VACCINE.2009.08.101

7 January 2021

Identifiers

DOI

1 reference

21 June 2017

1 reference